152 related articles for article (PubMed ID: 34796642)
1. Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions.
Gadhavi J; Shah S; Sinha T; Jain A; Gupta S
FEBS J; 2022 May; 289(9):2562-2577. PubMed ID: 34796642
[TBL] [Abstract][Full Text] [Related]
2. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils.
Guru KrishnaKumar V; Baweja L; Ralhan K; Gupta S
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2590-2604. PubMed ID: 30071272
[TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.
Acosta DM; Mancinelli C; Bracken C; Eliezer D
J Biol Chem; 2022 Jan; 298(1):101442. PubMed ID: 34838590
[TBL] [Abstract][Full Text] [Related]
4. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.
Shah SJA; Zhang Q; Guo J; Liu H; Liu H; Villà-Freixa J
ACS Chem Neurosci; 2023 Nov; 14(21):3959-3971. PubMed ID: 37830541
[TBL] [Abstract][Full Text] [Related]
5. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.
Inoue M; Konno T; Tainaka K; Nakata E; Yoshida HO; Morii T
Biochemistry; 2012 Feb; 51(7):1396-406. PubMed ID: 22304362
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment
Shah SJA; Zhong H; Zhang Q; Liu H
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269542
[TBL] [Abstract][Full Text] [Related]
7. Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.
Haj-Yahya M; Lashuel HA
J Am Chem Soc; 2018 May; 140(21):6611-6621. PubMed ID: 29684271
[TBL] [Abstract][Full Text] [Related]
8. Disease-associated patterns of acetylation stabilize tau fibril formation.
Li L; Nguyen BA; Mullapudi V; Li Y; Saelices L; Joachimiak LA
Structure; 2023 Sep; 31(9):1025-1037.e4. PubMed ID: 37348495
[TBL] [Abstract][Full Text] [Related]
9. Acetylation discriminates disease-specific tau deposition.
Chakraborty P; Rivière G; Hebestreit A; de Opakua AI; Vorberg IM; Andreas LB; Zweckstetter M
Nat Commun; 2023 Sep; 14(1):5919. PubMed ID: 37739953
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.
Thomas SN; Yang AJ
Methods Mol Biol; 2017; 1523():161-177. PubMed ID: 27975250
[TBL] [Abstract][Full Text] [Related]
11. Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease.
Balmik AA; Chinnathambi S
Cell Commun Signal; 2021 May; 19(1):51. PubMed ID: 33962636
[TBL] [Abstract][Full Text] [Related]
12. Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.
Thomas SN; Funk KE; Wan Y; Liao Z; Davies P; Kuret J; Yang AJ
Acta Neuropathol; 2012 Jan; 123(1):105-17. PubMed ID: 22033876
[TBL] [Abstract][Full Text] [Related]
13. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity.
Arya S; Ganguly P; Arsiccio A; Claud SL; Trapp B; Schonfeld GE; Liu X; Lazar Cantrell K; Shea JE; Bowers MT
J Phys Chem B; 2020 Oct; 124(40):8772-8783. PubMed ID: 32816481
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.
Huseby CJ; Hoffman CN; Cooper GL; Cocuron JC; Alonso AP; Thomas SN; Yang AJ; Kuret J
J Alzheimers Dis; 2019; 71(3):979-991. PubMed ID: 31450505
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
[TBL] [Abstract][Full Text] [Related]
16. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform.
Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R
Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553
[TBL] [Abstract][Full Text] [Related]
17. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
18. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
19. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
[TBL] [Abstract][Full Text] [Related]
20. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.
Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA
Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
